Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01093 CSPC PHARMA
RT Nominal up7.730 +0.030 (+0.390%)
Research Report

25/08/2025 16:01

{I-bank focus}Citi raises CSPC Pharma (01093) to HKD12.1

[ET Net News Agency, 25 August 2025] Citi raised the target price for CSPC Pharma (01093) to HKD12.1 from HKD9.2 and maintained the "buy" rating. ... more View All

16/06/2025 16:01

{I-bank focus}Nomura raises CSPC Pharma (01093) to HKD10.22

[ET Net News Agency, 16 June 2025] Nomura raised the target price for CSPC Pharma (01093) to HKD10.22 from HKD8.02 and maintained the "buy" rating. ... more View All

1

Remark: Real time quote last updated: 04/12/2025 10:05
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.